OneHealthDrugs
COST (European Cooperation in Science and Technology)
SURVEY 2. Compounds databases publicly available
4 April 2023

SURVEY 2. Compounds databases publicly available

Find out more →
SURVEY 1. Survey on research perspectives for drug development targeting vector-borne diseases and environmental impact. (WG6).

SURVEY 1. Survey on research perspectives for drug development targeting vector-borne diseases and environmental impact. (WG6).

Find out more →

SURVEY 3. HITS and LEADS profiles with anti VPDB activity

Find out more →
SURVEY 4. Available technologies in the OHD network

SURVEY 4. Available technologies in the OHD network

Find out more →
All SURVEYS list from the OneHealthdrugs network

All SURVEYS list from the OneHealthdrugs network

Find out more →
COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file
Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi

×